Jim Cramer’s Bold Predictions About These 10 Healthcare Stocks

6. McKesson Corporation (NYSE:MCK)

Number of Hedge Fund Holders In Q3 2024: 57

Date of Cramer’s Comments: 10-01-24/10-02-24

Performance Since Then: 14.6%

McKesson Corporation (NYSE:MCK) is one of the biggest pharmacy benefits managers in the US. It is a classic stock that is one of the middlemen that President-elect Trump has vowed to take on. During the second half, McKesson Corporation (NYSE:MCK)’s stock has been driven by the sentiment surrounding the middlemen and its earnings. After struggling with pharmacy revenue in Q2, the stock soared by 16% in November when McKesson Corporation (NYSE:MCK) raised full-year profit per share guidance to $32.40 to $33 per share, from an earlier $31.75 and $32.55. However, the shares have lost 9% since late November due to the aforementioned reasons. Here’s what Cramer said in October:

“It’s time to buy it. You know they’re not just a middleman. They do a lot of good things and I think the stock has had way too big a hit. It’s now selling at a below-market multiple. I’m ready to start buying. Don’t buy all at once. Buy in a pyramid style.”